{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:53:54Z","timestamp":1771048434623,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.08712"],"award-info":[{"award-number":["2020.08712"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["SFRH\/BPD\/122871\/2016"],"award-info":[{"award-number":["SFRH\/BPD\/122871\/2016"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012371","name":"Faculty of Science and Engineering, University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["17104"],"award-info":[{"award-number":["17104"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["GOIPG\/2015\/3148"],"award-info":[{"award-number":["GOIPG\/2015\/3148"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejphar.2024.177234","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:17:53Z","timestamp":1735060673000},"page":"177234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Isoquinolinequinone N-oxides with diverging mechanisms of action induce collateral sensitivity against multidrug resistant cancer cells"],"prefix":"10.1016","volume":"988","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7354-4338","authenticated-orcid":false,"given":"M\u00e9lanie A.G.","family":"Barbosa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-0802","authenticated-orcid":false,"given":"Ryan D.","family":"Kruschel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6407-4787","authenticated-orcid":false,"given":"Maria Jo\u00e3o","family":"Almeida","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7255-3400","authenticated-orcid":false,"given":"R\u00faben F.","family":"Pereira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-1917","authenticated-orcid":false,"given":"Cristina P.R.","family":"Xavier","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-1638","authenticated-orcid":false,"given":"Florence O.","family":"McCarthy","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7801-4643","authenticated-orcid":false,"given":"M. Helena","family":"Vasconcelos","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177234_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jconrel.2021.12.014","article-title":"Spatio-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density","volume":"341","author":"Ahmed-Cox","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2024.177234_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fphys.2017.00605","article-title":"Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening","volume":"8","author":"Amaral","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2024.177234_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100645","article-title":"The multi-factorial nature of clinical multidrug resistance in cancer","volume":"46","author":"Assaraf","year":"2019","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejphar.2024.177234_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8849568","article-title":"Synthesis and biological screening of new 4-hydroxycoumarin derivatives and their palladium(II) complexes","volume":"2021","author":"Avdovi\u0107","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2024.177234_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010190","article-title":"3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs","volume":"14","author":"Barbosa","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.177234_bib6","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177234_bib7","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.celrep.2017.05.014","article-title":"Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation","volume":"19","author":"Calvert","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2024.177234_bib8","article-title":"Danazol mediates collateral sensitivity via STAT3\/Myc related pathway in multidrug-resistant cancer cells","volume":"9","author":"Chang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177234_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","article-title":"Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis","volume":"27","author":"Chen","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2024.177234_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2024.177234_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/0008-5472.CAN-19-1407","article-title":"Unshielding multidrug resistant cancer through selective iron depletion of P-Glycoprotein-Expressing cells","volume":"80","author":"Cserepes","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177234_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","article-title":"Modulating ROS to overcome multidrug resistance in cancer","volume":"41","author":"Cui","year":"2018","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejphar.2024.177234_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41419-022-05044-9","article-title":"High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1\/MRP1 upregulation","volume":"13","author":"de Souza","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2024.177234_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/molecules18010721","article-title":"Synthesis and in vitro antiproliferative activity of new phenylaminoisoquinolinequinones against cancer cell lines","volume":"18","author":"Delgado","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2024.177234_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41598-017-00791-8","article-title":"Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer","volume":"7","author":"Dhawan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177234_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2407-12-4","article-title":"HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast","volume":"12","author":"Doublier","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2024.177234_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.01.009","article-title":"Collateral sensitivity of natural products in drug-resistant cancer cells","volume":"38","author":"Efferth","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejphar.2024.177234_bib18","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.molcel.2023.10.020","article-title":"Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest","volume":"83","author":"Foy","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2024.177234_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1535-7163.MCT-16-0333-T","article-title":"Identification and validation of compounds selectively killing resistant cancer: delineating cell line-specific effects from P-Glycoprotein-Induced toxicity","volume":"16","author":"F\u00fcredi","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2024.177234_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2019.07.009","article-title":"MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells","volume":"168","author":"Gana","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177234_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a better understanding of the complexity of cancer drug resistance","volume":"56","author":"Gottesman","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2024.177234_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100795","article-title":"Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: beyond pharmacological inhibition","volume":"59","author":"Hanssen","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejphar.2024.177234_bib23","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1021\/acs.jmedchem.4c00705","article-title":"Discovery of potent Isoquinolinequinone N-oxides to overcome cancer multidrug resistance","volume":"67","author":"Kruschel","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177234_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1039\/C9OB02441G","article-title":"Isoquinolinequinone N-oxides as anticancer agents effective against drug resistant cell lines","volume":"18","author":"Kruschel","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejphar.2024.177234_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2014.07.020","article-title":"Collateral sensitivity: ABCG2-overexpressing cells are more vulnerable to oxidative stress","volume":"76","author":"Krzy\u017canowski","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2024.177234_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbiomolbio.2021.05.002","article-title":"ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs)","volume":"165","author":"Kuczler","year":"2021","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ejphar.2024.177234_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2009.09.012","article-title":"P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil","volume":"491","author":"Laberge","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2024.177234_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jb\/mvac032","article-title":"Down-regulation of ABCB1 by collateral sensitivity drugs reverses multidrug resistance and up-regulates enolase I","volume":"172","author":"Limniatis","year":"2022","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejphar.2024.177234_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111584","article-title":"4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of \u03b2-tubulin","volume":"181","author":"Lin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177234_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep44541","article-title":"Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles","volume":"7","author":"Lopes-Rodrigues","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177234_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bmc.2016.11.023","article-title":"A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells","volume":"25","author":"Lopes-Rodrigues","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177234_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12935-016-0315-4","article-title":"Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa","volume":"16","author":"Murad","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2024.177234_bib33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41598-018-19325-x","article-title":"Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells","volume":"8","author":"Nanayakkara","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177234_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1747-0285.2011.01089.x","article-title":"New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitors","volume":"78","author":"Palmeira","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2024.177234_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2011.10.004","article-title":"Dual inhibitors of P-glycoprotein and tumor cell growth: (Re)discovering thioxanthones","volume":"83","author":"Palmeira","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177234_bib36","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1021\/acs.jmedchem.2c00076","article-title":"Structure-activity relationships of 8-hydroxyquinoline-derived mannich bases with tertiary amines targeting multidrug-resistant cancer","volume":"65","author":"Pape","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177234_bib37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejmech.2017.02.064","article-title":"Ferrocene-embedded flavonoids targeting the Achilles heel of multidrug-resistant cancer cells through collateral sensitivity","volume":"130","author":"P\u00e9r\u00e8s","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177234_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/joc.2006.18.1.66","article-title":"Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs","volume":"18","author":"Pesic","year":"2006","journal-title":"J. Chemother."},{"key":"10.1016\/j.ejphar.2024.177234_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmpb.2015.02.006","article-title":"AnaSP: a software suite for automatic image analysis of multicellular spheroids","volume":"119","author":"Piccinini","year":"2015","journal-title":"Comput. Methods Progr. Biomed."},{"key":"10.1016\/j.ejphar.2024.177234_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopha.2011.04.015","article-title":"The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines","volume":"65","author":"Podolski-Reni\u0107","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177234_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215308","article-title":"New therapeutic strategy for overcoming multidrug resistance in cancer cells with pyrazolo[3,4-d]pyrimidine tyrosine kinase inhibitors","volume":"13","author":"Podolski-Reni\u0107","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.177234_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00280-013-2247-1","article-title":"Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing","volume":"72","author":"Podolski-Reni\u0107","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177234_bib43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1055\/a-0651-8141","article-title":"Triterpenoids from momordica balsamina with a collateral sensitivity effect for tackling multidrug resistance in cancer cells","volume":"84","author":"Ramalhete","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.ejphar.2024.177234_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00599","article-title":"Epoxylathyrane derivatives as MDR-selective compounds for disabling multidrug resistance in cancer","volume":"11","author":"Reis","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177234_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093333","article-title":"MRP1-Collateral sensitizers as a novel therapeutic approach in resistant cancer therapy: an in vitro and in vivo study in lung resistant tumor","volume":"21","author":"Riganti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177234_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113354","article-title":"Triterpenes from Momordica balsamina (African pumpkin): ABCB1 inhibition and synergistic interaction with doxorubicin in resistant cancer cells","volume":"203","author":"Silva","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejphar.2024.177234_bib47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2024.177234_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010200","article-title":"Deep sequencing analysis reveals distinctive non-coding RNAs when comparing tumor multidrug-resistant cells and extracellular vesicles with drug-sensitive counterparts","volume":"12","author":"Sousa","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.177234_bib49","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202211087","article-title":"The molecular architecture of cell cycle arrest","volume":"18","author":"Stallaert","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejphar.2024.177234_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00280-015-2821-9","article-title":"Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives","volume":"76","author":"Stankovi\u0107","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177234_bib51","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1021\/cr4006236","article-title":"Targeting the achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance","volume":"114","author":"Szak\u00e1cs","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2024.177234_bib52","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2024.177234_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104660","article-title":"SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells","volume":"153","author":"Xu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.177234_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00487","article-title":"Reversal of multidrug resistance in cancer by multi-functional flavonoids","volume":"9","author":"Ye","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2024.177234_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2024.177234_bib56","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5082\/6\/3\/035001","article-title":"Three-dimensional printing of Hela cells for cervical tumor model in vitro","volume":"6","author":"Zhao","year":"2014","journal-title":"Biofabrication"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T10:16:26Z","timestamp":1742033786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924009245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":56,"alternative-id":["S0014299924009245"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177234","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoquinolinequinone N-oxides with diverging mechanisms of action induce collateral sensitivity against multidrug resistant cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177234"}}